Cyclo-oxygenase-1 and cyclo-oxygenase-2 and cardiovascular system (Q28192302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Cyclo-oxygenase-1 and cyclo-oxygenase-2 and cardiovascular system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

M Lettino

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

F Cantù

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Mariani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

33 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

S12-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

Prostacyclin and thromboxane synthases

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Prostanoid receptors. Structure, function, and distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Physiological and pathophysiological roles of eicosanoids in the microcirculation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Cyclo-oxygenase isoenzymes: physiological and pharmacological role

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Antiplatelet drugs. A comparative review

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Aspirin selectively inhibits prostaglandin production in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Low-dose aspirin fails to inhibit increased platelet reactivity in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Platelet activation mechanisms and markers in arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980154-7

7 January 2021

10.1016/S1590-8658(01)80154-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11827357%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference